web analytics

Feasibility study supports the use of intralymphatic injections of Diamyd®

A feasibility study performed as a Master Thesis at Uppsala University and supervised by Diamyd Medical, supports the use of ultrasound guided intralymphatic injections for clinical routine use. This pilot study is based on interviews with and answers to questionnaires from selected radiologists and answers to questionnaires from selected study nurses participating in the ongoing DIAGNODE-2 trial where the antigen-specific immunotherapy Diamyd® is administered directly into a lymph node.
The insights from the study are in line with previous conclusions regarding the feasibility of

Source: Feasibility study supports the use of intralymphatic injections of Diamyd®

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.